Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial.
Yanai H, Levine A, Hirsch A, Boneh RS, Kopylov U, Eran HB, Cohen NA, Ron Y, Goren I, Leibovitzh H, Wardi J, Zittan E, Ziv-Baran T, Abramas L, Fliss-Isakov N, Raykhel B, Gik TP, Dotan I, Maharshak N. Yanai H, et al. Among authors: leibovitzh h. Lancet Gastroenterol Hepatol. 2022 Jan;7(1):49-59. doi: 10.1016/S2468-1253(21)00299-5. Epub 2021 Nov 2. Lancet Gastroenterol Hepatol. 2022. PMID: 34739863 Clinical Trial.
Correlation of 18F-FDG PET/MRE Metrics with Inflammatory Biomarkers in Patients with Crohn's Disease: A Pilot Study.
Domachevsky L, Leibovitzh H, Avni-Biron I, Lichtenstein L, Goldberg N, Nidam M, Groshar D, Bernstine H, Ben-Bassat O. Domachevsky L, et al. Among authors: leibovitzh h. Contrast Media Mol Imaging. 2017 Sep 19;2017:7167292. doi: 10.1155/2017/7167292. eCollection 2017. Contrast Media Mol Imaging. 2017. PMID: 29097934 Free PMC article. Clinical Trial.
Helicobacter pylori infection is positively associated with an increased BMI, irrespective of socioeconomic status and other confounders: a cohort study.
Suki M, Leibovici Weissman Y, Boltin D, Itskoviz D, Tsadok Perets T, Comaneshter D, Cohen A, Niv Y, Dotan I, Leibovitzh H, Levi Z. Suki M, et al. Among authors: leibovitzh h. Eur J Gastroenterol Hepatol. 2018 Feb;30(2):143-148. doi: 10.1097/MEG.0000000000001014. Eur J Gastroenterol Hepatol. 2018. PMID: 29120907
Early Indolent Course of Crohn's Disease in Newly Diagnosed Patients Is Not Rare and Possibly Predictable.
Yanai H, Goren I, Godny L, Maharshak N, Ron Y, Avni Biron I, Leibovitzh H, Banai Eran H, Aharoni Golan M, Rabinowitz K, Ziv Baran T, Lavie I, Yadgar K, Zonensain K, Kopylov U, Ben Horin S, Eliakim R, Waterman M, Chowers Y, Ben-Shachar S, Dotan I; Israeli IBD Research Nucleus. Yanai H, et al. Among authors: leibovitzh h. Clin Gastroenterol Hepatol. 2021 Aug;19(8):1564-1572.e5. doi: 10.1016/j.cgh.2020.06.069. Epub 2020 Jul 3. Clin Gastroenterol Hepatol. 2021. PMID: 32629126
Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study.
Cohen NA, Plevris N, Kopylov U, Grinman A, Ungar B, Yanai H, Leibovitzh H, Isakov NF, Hirsch A, Ritter E, Ron Y, Shitrit AB, Goldin E, Dotan I, Horin SB, Lees CW, Maharshak N. Cohen NA, et al. Among authors: leibovitzh h. United European Gastroenterol J. 2020 Nov;8(9):1076-1085. doi: 10.1177/2050640620951400. Epub 2020 Aug 17. United European Gastroenterol J. 2020. PMID: 32807038 Free PMC article.
Dose-dependent association of proton pump inhibitors use with gastric intestinal metaplasia among Helicobacter pylori-positive patients.
Snir Y, Leibovitzh H, Leibovici-Weissman Y, Vilkin A, Cohen AD, Shochat T, Niv Y, Dotan I, Feldhamer I, Boltin D, Levi Z. Snir Y, et al. Among authors: leibovitzh h. United European Gastroenterol J. 2021 Apr;9(3):343-353. doi: 10.1177/2050640620951403. Epub 2021 Mar 18. United European Gastroenterol J. 2021. PMID: 32962566 Free PMC article.
Specialized Emergency Department Assessment and Multidisciplinary Intervention After Discharge Improve Management of Patients With Inflammatory Bowel Diseases.
Goren I, Barkan R, Biron IA, Leibovitzh H, Golan MA, Eran HB, Snir Y, Broitman Y, Konikoff T, Amir-Barak H, Yafee H, Adani E, Shiber S, Steiner H, Drescher MJ, Dotan I, Yanai H; Israeli IBD Research Nucleus (IIRN). Goren I, et al. Among authors: leibovitzh h. J Clin Gastroenterol. 2022 Feb 1;56(2):148-153. doi: 10.1097/MCG.0000000000001490. J Clin Gastroenterol. 2022. PMID: 33471484
Mediterranean-Like Dietary Pattern Associations With Gut Microbiome Composition and Subclinical Gastrointestinal Inflammation.
Turpin W, Dong M, Sasson G, Raygoza Garay JA, Espin-Garcia O, Lee SH, Neustaeter A, Smith MI, Leibovitzh H, Guttman DS, Goethel A, Griffiths AM, Huynh HQ, Dieleman LA, Panaccione R, Steinhart AH, Silverberg MS, Aumais G, Jacobson K, Mack D, Murthy SK, Marshall JK, Bernstein CN, Abreu MT, Moayyedi P, Paterson AD; Crohn’s and Colitis Canada (CCC) Genetic, Environmental, Microbial (GEM) Project Research Consortium; Xu W, Croitoru K. Turpin W, et al. Among authors: leibovitzh h. Gastroenterology. 2022 Sep;163(3):685-698. doi: 10.1053/j.gastro.2022.05.037. Epub 2022 May 26. Gastroenterology. 2022. PMID: 35643175
Autoimmune Pancreatitis in Patients with Inflammatory Bowel Disease: A Real-World Multicentre Collaborative ECCO CONFER Study.
Eder P, Verstock B, Culver E, Dragoni G, Kredel LI, Wypych J, de Paredes AGG, Kaniewska M, Leibovitzh H, Lobaton T, Truyens M, Oracz G, Ribaldone DG, Starzyńska T, Badaoui A, Rahier JF, Bezzio C, Bossuyt P, Falloon K, Pugliese D, Frakes Vozzo C, Jess T, Larsen L, Olesen SS, Pal P, Chaparro M, Dror D, Ellul P, Gromny I, Janiak M, Maciejewska K, Peleg N, Bar-Gil Shitrit A, Szwed Ł, Talar-Wojnarowska R, Snir Y, Weisshof R, Zittan E, Miechowicz I, Goren I. Eder P, et al. Among authors: leibovitzh h. J Crohns Colitis. 2023 Nov 24;17(11):1791-1799. doi: 10.1093/ecco-jcc/jjad097. J Crohns Colitis. 2023. PMID: 37283545 Free PMC article.
21 results